An official website of the United States government
NIH Guide: Weekly Index for September 24, 2021
Weekly NIH Guide Notices
September 24, 2021
Policy Notices
-
Notice to Extend PA-20-074 "Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support (R18)"
(NOT-HS-21-021)Agency for Healthcare Research and Quality
-
RESCINDED - Announcement of Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Awards
(NOT-OD-21-177)National Institutes of Health
General Notices
-
Change to NIDCD Administrative Reduction Guidance for Modular R01 Awards
(NOT-DC-21-005)National Institute on Deafness and Other Communication Disorders
-
NIDCR Guidance on Applications for Investigator-Initiated Clinical Trials
(NOT-DE-21-014)National Institute of Dental and Craniofacial Research
-
Notice to Rescind NOT-EB-21-018 Blueprint MedTech: Prototype Developer (U18 Clinical Trial Not Allowed)
(NOT-EB-21-027)National Institute of Biomedical Imaging and Bioengineering
-
Autism Centers of Excellence (ACE) Funding Opportunity Announcements: Frequently Asked Questions
(NOT-HD-21-045)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute on Deafness and Other Communication DisordersNational Institute of Environmental Health SciencesNational Institute of Mental HealthNational Institute of Neurological Disorders and Stroke
-
NIH Request for Information (RFI): Search Capabilities across the Biomedical Landscape for NIH-wide Data Discovery
(NOT-OD-21-187)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of Correction to Salary information in PAR-21-295, NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
(NOT-CA-21-116)National Cancer Institute
-
Notice of Correction to PAR-21-166 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)"
(NOT-CA-21-119)National Cancer Institute
-
Notice of Early Termination of RFA-CA-21-057, "A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Not Allowed)"
(NOT-CA-21-120)National Cancer Institute
-
Notice of NIDA's Participation in PA-20-144, "Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)"
(NOT-DA-21-075)National Institute on Drug Abuse
-
Notice of NIDA's Participation in PA-20-145, "Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)"
(NOT-DA-21-076)National Institute on Drug Abuse
-
Notice of Early Expiration of PAR-21-022, "Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)"
(NOT-DA-21-077)National Institute on Drug Abuse
-
Notice of Early Expiration of PAR-21-023, "Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)"
(NOT-DA-21-078)National Institute on Drug Abuse
-
Notice of clarification in RFA-DA-22-022, " Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional)"
(NOT-DA-21-083)National Institute on Drug Abuse
-
Notice of Change to Award Information and Application and Submission Instructions for RFA-DK-21-019, National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional)
(NOT-DK-21-027)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Change to Research Strategy Section Page Limits for RFA-DK-21-502, Limited Competition for the Data Coordinating Center (DCC) for the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) (U24 Clinical Trial Optional)
(NOT-DK-21-028)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Extension of Application Due Date and Funding Opportunity Announcement (FOA) Identified under Announcement Type for RFA-DK-20-028, Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
(NOT-DK-21-029)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Change to Key Dates of RFA-MH-21-175, "BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)"
(NOT-MH-21-345)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences Research
-
Notice of Change to NOT-NS-20-038 "Notice of Special Interest: Administrative Supplement for the NINDS Research Education Program for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supp)"
(NOT-NS-22-027)National Institute of Neurological Disorders and Stroke
Notices of Special Interest
-
Notice of Special Interest (NOSI): Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)
(NOT-AI-21-074)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Promoting Pain Research Within the NIAMS Mission Areas
(NOT-AR-22-007)National Institute of Arthritis and Musculoskeletal and Skin Diseases
Funding Opportunities
-
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed)
(PAR-21-326)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): December 01, 2021
-
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
(PAR-21-329)National Cancer InstituteApplication Receipt Date(s): November 5, 2024
-
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
(PAR-21-333)National Cancer InstituteApplication Receipt Date(s): November 4, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
(PAR-21-337)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesApplication Receipt Date(s): September 13, 2024
-
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
(PAR-21-338)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesApplication Receipt Date(s): September 13, 2024
-
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
(PAR-22-035)National Institute of Mental HealthApplication Receipt Date(s): January 5, 2023
-
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
(PAR-22-036)National Institute of Mental HealthApplication Receipt Date(s): January 12, 2023
-
Limited Competition:Caenorhabditis Intervention Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-AG-22-028)National Institute on AgingApplication Receipt Date(s): October 27, 2021
-
Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01 Clinical Trial Not Allowed)
(RFA-AG-22-029)National Institute on AgingApplication Receipt Date(s): October 27, 2021
-
SUNBEAM - Analysis and Bioinformatics Center (ABC) (UM1 Clinical Trial Not Allowed)
(RFA-AI-21-060)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): February 15, 2022
-
Development of Microbiome-Related Approaches for Diagnosis/Mitigation/Treatment of Radiation Injuries (U01 Clinical Trial Not Allowed)
(RFA-AI-21-068)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): February 09, 2022
-
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
(RFA-CA-21-059)National Cancer InstituteApplication Receipt Date(s): November 18, 2021
-
Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional
(RFA-FD-22-003)Food and Drug AdministrationApplication Receipt Date(s): November 29, 2021
-
Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
(RFA-MH-22-100)National Institute of Mental HealthApplication Receipt Date(s): December 09, 2021
-
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)
(RFA-OD-21-007)Office of the Director, NIHNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Center for Complementary and Integrative HealthDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Multiple dates, see announcement.
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster